June 20, 2026

#immunotherapy — Saturday, June 20, 2026 (2 items)

hot top new

0		💬 0	Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study. (linkinghub.elsevier.com)	Shen L … Ji J The Lancet 2026-06-20	#cancer #clinical trial #immunotherapy #chemotherapy #gastric
0		💬 0	Tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma (frontMIND): a global, phase 3, randomised, double-blind, placebo-controlled trial. (linkinghub.elsevier.com)	Lenz G … Vitolo U The Lancet 2026-06-20	#antibody #clinical trial #immunotherapy #chemotherapy #lymphoma